Skip to main content
. 2017 Dec 11;9(5):5993–6006. doi: 10.18632/oncotarget.23202

Figure 8. Inhibitor assays.

Figure 8

(A, B) Cell viability of AGS and SNU-484 cells with or without z-VAD (z-VAD- fmk) or Pifithrin-α.AGS and SNU-484 cells were treated with 10 μM of z-VAD- fmk and 30μM of Pifithrin for 1 h before scutellarein treatment. The cell viability was determined by MTT assay. (C) DAPI Fluorescent staining of AGS and SNU-484 cells treated with or without 20 μM of z-VAD- fmk and co-treated with scutellarein for 24h and was examined under light microscopy and fluorescence microscopy (×400).